| Literature DB >> 31456965 |
Abedin Saghafipour1, Ahmad Mousazadeh-Mojarrad2, Niloofar Arzamani3, Zakyeh Telmadarraiy4, Rezvan Rajabzadeh5,2, Kourosh Arzamani2.
Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF) is a prevalent tick-borne disease in different regions of Iran. This molecular and serologic study was performed to investigate the Crimean-Congo hemorrhagic fever virus (CCHFV) in collected ticks and in blood samples of some domestic animals in North Khorasan, Northeast of Iran.Entities:
Keywords: Crimean-Congo hemorrhagic fever; Iran; Molecular technique; Serological test; Ticks
Year: 2019 PMID: 31456965 PMCID: PMC6708110 DOI: 10.34171/mjiri.33.41
Source DB: PubMed Journal: Med J Islam Repub Iran ISSN: 1016-1430
Fig. 1Molecular details of the tick species were collected and examined for the presence of CCHF virus genome, North Khorasan, Northeast of Iran
| Species | Ticks | Infection status N (%) | ||||||||
| Life cycle stage | Gender | Host type | Total infection rate | |||||||
| N | (%) | Nymph | Adult | Male | Female | Cow | Sheep | Goat | N (% ,CI95%) | |
|
| 20 | 32.25 | 1 | 2 | 3 | 0 | 2 | 1 | 0 | 3 (15, 9.41 – 20.59) |
|
| 4 | 6.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 (0%) |
|
| 2 | 3.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 (0%) |
|
| 31 | 50.00 | 0 | 2 | 0 | 2 | 0 | 1 | 1 | 2 (6.45, 4.33 – 8.58) |
|
| 2 | 3.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 (0%) |
|
| 3 | 4.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 (0%) |
| Total | 62 | (100) | 1 | 4 | 3 | 2 | 2 | 2 | 1 | 5 (8.06, 6.22 – 9.91) |
Crimean-Congo hemorrhagic fever virus (CCHFV) seroprevalence in domestic animals, North Khorasan, Northeast of Iran
| County | Animal |
Seroprevalence | Assay | ||
|
Cow |
Sheep |
Goat | |||
| Esfarayen | 0 | 22/5 | 6/2 | (28/7) (25, 15.39-30.06) | IgG ELISA |
| Raz and Jargalan | 2/0 | 7/2 | 1/0 | (10/2) (20, 13.45 –43.69) | IgG ELISA |
| Garmeh | 0 | 7/1 | 0 | (7/1) (14.28, 5.21 –23.35) | IgG ELISA |
| Maneh and Samalqan | 6/0 | 13/3 | 3/0 | (22/3) (13.63, 13.43 –32.73) | IgG ELISA |
| Shirvan | 2/0 | 21/3 | 8/1 | (31/4) (12.90, 9.04 – 19.53) | IgG ELISA |
| Jajarm | 0 | 8/0 | 1/1 | (9/1) 0 | IgG ELISA |
| Bojnurd | 1/0 | 13/1 | 5/1 | (19/2) (10.53, 6.29 – 14.76) | IgG ELISA |
| Faruj | 0 | 8/1 | 2/0 | (10/1) (10.00, 4.42 – 15.58) | IgG ELISA |
| Total | (11/0) 0.00% | (99/16) ( 16.2, 8.9 – 23.5) | (26/5) (19.2, 4.1 – 34.3) | (136/21) (15.44, 13.25 –17.63) | IgG ELISA |
Fig. 2